Nutraceuticals and coronary heart disease

Current Opinion in Cardiology

Volumn 28, Issue 4, 2013, Pages 475-482

  Garcia Rios, Antonio ^a   Delgado Lista, Javier ^b   Alcala Diaz, Juan Francisco ^b   Lopez Miranda, Jose ^a   Perez Martinez, Pablo ^b  

^a UNIVERSITY OF CÓRDOBA   (Spain)

^b NONE

Author keywords

coronary heart disease; functional foods; Mediterranean diet; nutraceuticals; olive oil

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; EZETIMIBE; ISOFLAVONE DERIVATIVE; MONOUNSATURATED FATTY ACID; NUTRACEUTICAL; OLEIC ACID; OLIVE OIL; PHYTOSTEROL; POLYPHENOL; RETINOL; VEGETABLE OIL;

CARDIOVASCULAR MORTALITY; DIET; FAT INTAKE; FIBER; HUMAN; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; REVIEW; VITAMIN SUPPLEMENTATION;

CORONARY DISEASE; DIETARY SUPPLEMENTS; HUMANS;

EID: 84879982667     PISSN: 02684705     EISSN: 15317080     Source Type: Journal    
DOI: 10.1097/HCO.0b013e32836081a5     Document Type: Review

References (93)

1. O'Flaherty M, Ford E, Allender S, et al. Coronary heart disease trends in England and Wales from 1984 to 2004: concealed levelling of mortality rates among young adults. Heart 2008; 94:178-181.
2. Mente A, Yusuf S, Islam S, et al. Metabolic syndrome and risk of acute myocardial infarction a case-control study of 26, 903 subjects from 52 countries. J Am Coll Cardiol 2010; 55:2390-2398.
3. Mottillo S, Filion KB, Genest J, et al. The metabolic syndrome and cardio-vascular risk a systematic review and meta-analysis. J Am Coll Cardiol 2010; 56:1113-1132.
4. Han JC, Lawlor DA, Kimm SY. Childhood obesity. Lancet 2010; 375:1737-1748.
5. Garcia-Rios A, Delgado-Lista J, Perez-Martinez P, et al. Genetic variations at the lipoprotein lipase gene influence plasma lipid concentrations and interact with plasma n-6 polyunsaturated fatty acids to modulate lipid metabolism. Atherosclerosis 2011; 218:416-422.
6. Garcia-Rios A, Perez-Martinez P, Fuentes F, et al. Genetic variations at ABCG5/G8 genes modulate plasma lipids concentrations in patients with familial hypercholesterolemia. Atherosclerosis 2010; 210:486-492.
7. Perez-Martinez P, Lopez-Miranda J, Cruz-Teno C, et al. Adiponectin gene variants are associated with insulin sensitivity in response to dietary fat consumption in Caucasian men. J Nutr 2008; 138:1609-1614.
8. Moreno JA, Perez-Jimenez F, Marin C, et al. The effect of dietary fat on LDL size is influenced by apolipoprotein E genotype in healthy subjects. J Nutr 2004; 134:2517-2522.
9. Garcia-Rios A, Perez-Martinez P, Delgado-Lista J, et al. Nutrigenetics of the lipoprotein metabolism. Mol Nutr Food Res 2012; 56:171-183.
10. Perez-Martinez P, Garcia-Rios A, Delgado-Lista J, et al. Metabolic syndrome: evidences for a personalized nutrition. Mol Nutr Food Res 2012; 56:67-76.
11. Ferguson JF, Phillips CM, Tierney AC, et al. Gene-nutrient interactions in the metabolic syndrome: single nucleotide polymorphisms in ADIPOQ and ADIPOR1 interact with plasma saturated fatty acids to modulate insulin resistance. Am J Clin Nutr 2010; 91:794-801.
12. Perez-Martinez P, Perez-Jimenez F, Bellido C, et al. A polymorphism exon 1 variant at the locus of the scavenger receptor class B type I (SCARB1) gene is associated with differences in insulin sensitivity in healthy people during the consumption of an olive oil-rich diet. J Clin Endocrinol Metab 2005; 90:2297-2300.
13. Lopez-Miranda J, Cruz G, Gomez P, et al. The influence of lipoprotein lipase gene variation on postprandial lipoprotein metabolism. J Clin Endocrinol Metab 2004; 89:4721-4728.
14. Perez-Martinez P, Delgado-Lista J, Garcia-Rios A, et al. Calpain-10 interacts with plasma saturated fatty acid concentrations to influence insulin resistance in individuals with the metabolic syndrome. Am J Clin Nutr 2011; 93:1136-1141.
15. Gomez P, Perez-Martinez P, Marin C, et al. APOA1 and APOA4 gene polymorphisms influence the effects of dietary fat on LDL particle size and oxidation in healthy young adults. J Nutr 2010; 140:773-778.
16. Perez-Martinez P, Garcia-Rios A, Delgado-Lista J, et al. Mediterranean diet rich in olive oil and obesity, metabolic syndrome and diabetes mellitus. Curr Pharm Des 2011; 17:769-777.
17. Marin C, Delgado-Lista J, Ramirez R, et al. Mediterranean diet reduces senescence-associated stress in endothelial cells. Age (Dordr) 2012; 34:1309-1316.
18. Perez-Martinez P, Moreno-Conde M, Cruz-Teno C, et al. Dietary fat differen-tially influences regulatory endothelial function during the postprandial state in patients with metabolic syndrome: from the LIPGENE study. Atherosclerosis 2010; 209:533-538.
19. Perez-Martinez P, Ordovas JM, Garcia-Rios A, et al. Consumption ofdietswith different type of fat influences triacylglycerols-rich lipoproteins particle num-ber and size during the postprandial state. Nutr Metab Cardiovasc Dis 2011; 21:39-45.
20. Nordmann AJ, Suter-Zimmermann K, Bucher HC, et al. Meta-analysis com-paring Mediterranean to low-fat diets for modification of cardiovascular risk factors. Am J Med 2011; 124:841-851; e842.
21. Kastorini CM, Milionis HJ, Esposito K, et al. The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534, 906 individuals. J Am Coll Cardiol 2011; 57:1299-1313.
22. Estruch R, Ros E, Salas-Salvadó J, et al. Primary Prevention of Cardiovascular Disease with a Mediterranean Diet. N Engl J Med 2013. doi:10.1056/NEJMoa1200303. [Epub ahead of print]
23. de Lorgeril M, Salen P, Martin JL, et al. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarc-tion:final reportof theLyon Diet Heart Study. Circulation 1999; 99:779-785.
24. Kris-Etherton P, Eckel RH, Howard BV, et al. AHA Science Advisory: Lyon Diet Heart Study. Benefits of a Mediterranean-style, National Cholesterol Education Program/American Heart Association Step I Dietary Pattern on Cardiovascular Disease. Circulation 2001; 103:1823-1825.
25. Covas MI, Konstantinidou V, Fito M. Olive oil and cardiovascular health. J Cardiovasc Pharmacol 2009; 54:477-482.
26. Lou-Bonafonte JM, Arnal C, Navarro MA, Osada J. Efficacy of bioactive compounds from extra virgin olive oil to modulate atherosclerosis develop-ment. Mol Nutr Food Res 2012; 56:1043-1057.
27. Lopez-Miranda J, Perez-Jimenez F, Ros E, et al. Olive oil and health: summary of the II international conference on olive oil and health consensus report, Jaen and Cordoba (Spain). Nutr Metab Cardiovasc Dis 2010; 20:284-294.
28. Escrich E, Moral R, Solanas M. Olive oil, an essential component of the Mediterranean diet, and breast cancer. Public Health Nutr 2011; 14:2323-2332.
29. Buckland G, Travier N, Barricarte A, et al. Olive oil intake and CHD in the European Prospective Investigation intoCancerand Nutrition Spanish cohort. Br J Nutr 2012; 108:2075-2082.
30. Buckland G, Mayen AL, Agudo A, et al. Oliveoil intakeand mortality within the Spanish population (EPIC-Spain). Am J Clin Nutr 2012; 96:142-149.
31. Perez-Jimenez F, Ruano J, Perez-Martinez P, et al. The influence ofolive oil on human health: not a question of fat alone. Mol Nutr Food Res 2007; 51:1199-1208.
32. Perez-Jimenez F, Alvarez de Cienfuegos G, Badimon L, et al. International conference on the healthy effect of virgin olive oil. Eur J Clin Invest 2005; 35:421-424.
33. De Felice DL. The nutraceutical revolution: its impact on food industry R&D. Trends Food Sci Technol 1995; 6:59-61.
34. Ross S. Functional foods: the Food and Drug Administration perspective. Am J Clin Nutr 2000; 71:1735S-1738S; discussion 1739S-1742S.
35. Rimm EB, Stampfer MJ, Ascherio A, et al. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993; 328:1450-1456.
36. Stampfer MJ, Hennekens CH, Manson JE, et al. Vitamin E consumption and the riskofcoronarydisease inwomen. N Engl J Med 1993; 328:1444-1449.
37. Keys A, Menotti A, Karvonen MJ, et al. The diet and 15-year death rate in the seven countries study. Am J Epidemiol 1986; 124:903-915.
38. Riccardi G, Giacco R, Rivellese AA. Dietary fat, insulin sensitivity and the metabolic syndrome. Clin Nutr 2004; 23:447-456.
39. Paniagua JA, de la Sacristana AG, Sanchez E, et al. A MUFA-rich diet improves posprandial glucose, lipid and GLP-1 responses in insulin-resistant subjects. J Am Coll Nutr 2007; 26:434-444.
40. Lopez S, Bermudez B, Pacheco YM, et al. Distinctive postprandial modulation of beta cell function and insulin sensitivity by dietary fats: monounsaturated compared with saturated fatty acids. Am J Clin Nutr 2008; 88:638-644.
41. Lozano A, Perez-Martinez P, Delgado-Lista J, et al. Body mass interacts with fatqualitytodetermine the postprandial lipoprotein response in healthyyoung adults. Nutr Metab Cardiovasc Dis 2012; 22:355-361.
42. Camargo A, Rangel-Zuniga OA, Pena-Orihuela P, et al. Postprandial changes in the proteome are modulated by dietary fat in patients with metabolic syndrome. J Nutr Biochem 2013; 24:318-324.
43. Covas MI, Nyyssonen K, Poulsen HE, et al. The effect of polyphenols in olive oil on heart disease risk factors: a randomized trial. Ann Intern Med 2006; 145:333-341.
44. Visioli F, Caruso D, Grande S, et al. Virgin Olive Oil Study (VOLOS): vasoprotective potential of extra virgin olive oil in mildly dyslipidemic patients. Eur J Nutr 2005; 44:121-127.
45. Bogani P, Galli C, Villa M, Visioli F. Postprandial anti-inflammatory and antioxidant effects of extra virgin olive oil. Atherosclerosis 2007; 190:181-186.
46. Oubina P, Sanchez-Muniz FJ, Rodenas S, Cuesta C. Eicosanoid production, thrombogenic ratio, and serum and LDL peroxides in normo-and hyperch-olesterolaemic post-menopausal women consuming two oleic acid-rich diets with different content of minor components. Br J Nutr 2001; 85:41-47.
47. Fito M, Cladellas M, de la Torre R, et al. Anti-inflammatory effect of virgin olive oil in stable coronary disease patients: a randomized, crossover, controlled trial. Eur J Clin Nutr 2008; 62:570-574.
48. Pacheco YM, Lopez S, Bermudez B, et al. Extra-virgin vs. refined olive oil on postprandial hemostatic markers in healthy subjects. J Thromb Haemost 2006; 4:1421-1422.
49. Camargo A, Delgado-Lista J, Garcia-Rios A, et al. Expression of proinflammatory, proatherogenic genes is reduced by the Mediterranean diet in elderly people. Br J Nutr 2012; 108:500-508.
50. Camargo A, Ruano J, Fernandez JM, et al. Gene expression changes in mononuclear cells in patients with metabolic syndrome after acute intake of phenol-rich virgin olive oil. BMC Genomics 2010; 11:253.
51. EFSA. Scientific Opinion on the substantiation of health claims related to polyphenols in olive and protection of LDL particles from oxidative damage (ID 1333, 1638, 1639, 1696, 2865), maintenance of normal blood HDL cho-lesterol concentrations (ID 1639), maintenance of normal blood pressure (ID 3781), 'anti-inflammatory properties' (ID 1882), 'contributes to the upper respiratory tract health' (ID 3468), 'can help to maintain a normal function of gastrointestinal tract' (3779), and 'contributes to body defences against external agents' (ID 3467) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 2011; 9:2033.
52. Wang C, Harris WS, Chung M, et al. n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary-and secondary-prevention studies: a systematic review. Am J Clin Nutr 2006; 84:5-17.
53. Investigators GP. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Preven-zione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 1999; 354:447-455.
54. Delgado-Lista J, Perez-Martinez P, Lopez-Miranda J, Perez-Jimenez F. Long chain omega-3 fatty acids and cardiovascular disease: a systematic review. Br J Nutr 2012; 107 (Suppl 2):S201-S213.
55. Rizos EC, Ntzani EE, Bika E, et al. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA 2012; 308:1024-1033.
56. ORIGIN Trial Investigators, Bosch J, Gerstein HC, Dagenais GR, et al. n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med 2012; 367:309-318.
57. Lee TH, Hoover RL, Williams JD, et al. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med 1985; 312:1217-1224.
58. Mishra A, Chaudhary A, Sethi S. Oxidized omega-3 fatty acids inhibit NF-kappaB activation via a PPARalpha-dependent pathway. Arterioscler Thromb Vasc Biol 2004; 24:1621-1627.
59. De Caterina R, Madonna R, Massaro M. Effects of omega-3 fatty acids on cytokinesand adhesion molecules. Curr Atheroscler Rep 2004; 6:485-491.
60. Schaefer MB, Wenzel A, Fischer T, et al. Fatty acids differentially influence phosphatidylinositol 3-kinase signal transduction in endothelial cells: impact on adhesion and apoptosis. Atherosclerosis 2008; 197:630-637.
61. Swann PG, Venton DL, Le Breton GC. Eicosapentaenoic acid and docosa-hexaenoic acid are antagonists at the thromboxane A2/prostaglandin H2 receptor in human platelets. FEBS Lett 1989; 243:244-246.
62. O'Keefe JH Jr, Abuissa H, Sastre A, et al. Effects of omega-3 fatty acids on resting heartrate, heartrate recoveryafterexercise, and heartratevariability in men with healed myocardial infarctions and depressed ejection fractions. Am J Cardiol 2006; 97:1127-1130.
63. Mozaffarian D, Stein PK, Prineas RJ, Siscovick DS. Dietary fish and omega-3 fatty acid consumption and heart rate variability in US adults. Circulation 2008; 117:1130-1137.
64. Tagawa H, Shimokawa H, Tagawa T, et al. Long-term treatment with eico-sapentaenoic acid augments both nitric oxide-mediated and non-nitric oxide-mediated endothelium-dependent forearm vasodilatation in patients with coronary artery disease. J Cardiovasc Pharmacol 1999; 33:633-640.
65. Schirmer SH, Werner CM, Binder SB, et al. Effects ofomega-3 fattyacids on postprandial triglycerides and monocyte activation. Atherosclerosis 2012; 225:166-172.
66. Czernichow S, Thomas D, Bruckert E. n-6 Fatty acids and cardiovascular health: a reviewof the evidencefordietary intake recommendations. Br J Nutr 2010; 104:788-796.
67. Hayakawa S, Yoshikawa D, Ishii H, et al. Association of plasma omega-3 to omega-6 polyunsaturated fatty acid ratio with complexity of coronary artery lesion. Intern Med 2012; 51:1009-1014.
68. Anderson JS, Nettleton JA, Hundley WG, et al. Associations of plasma phospholipid omega-6 and omega-3 polyunsaturated fatty acid levels and MRI measures of cardiovascular structure and function: the multiethnic study of atherosclerosis. J Nutr Metab 2011; 2011:315134.
69. Neil HA, Ceglarek U, Thiery J, et al. Impact of atorvastatin and omega-3 ethyl esters 90 on plasma plant sterol concentrations and cholesterol synthesis in type 2 diabetes: a randomised placebo controlled factorial trial. Atherosclero-sis 2010; 213:512-517.
70. Abumweis SS, Barake R, Jones PJ. Plant sterols/stanols as cholesterol lowering agents: a meta-analysis of randomized controlled trials. Food Nutr Res 2008; 52.
71. Rajaratnam RA, Gylling H, Miettinen TA. Independent association of serum squalene and noncholesterol sterols with coronary artery disease in post-menopausal women. J Am Coll Cardiol 2000; 35:1185-1191.
72. Miettinen TA, Gylling H, Strandberg T, Sarna S. Baseline serum cholestanol as predictor of recurrent coronary events in subgroup of Scandinavian simvas-tatin survival study. Finnish 4S Investigators. BMJ 1998; 316:1127-1130.
73. Lin X, Racette SB, Lefevre M, et al. Combined effects of ezetimibe and phytosterols on cholesterol metabolism: a randomized, controlled feeding study in humans. Circulation 2011; 124:596-601.
74. Estruch R, Martinez-Gonzalez MA, Corella D, et al. Effects of dietary fibre intake on risk factors for cardiovascular disease in subjects at high risk. J Epidemiol Commun Health 2009; 63:582-588.
75. Reiner Z, Catapano AL, De Backer G, et al. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dysli-pidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 2011; 32:1769-1818.
76. Liu S, Buring JE, Sesso HD, et al. A prospective study of dietary fiber intake and risk of cardiovascular disease among women. J Am Coll Cardiol 2002; 39:49-56.
77. Merchant AT, Hu FB, Spiegelman D, et al. Dietary fiber reduces peripheral arterial disease risk in men. J Nutr 2003; 133:3658-3663.
78. Pereira MA, O'Reilly E, Augustsson K, et al. Dietaryfiber and riskof coronary heart disease: a pooled analysis of cohort studies. Arch Intern Med 2004; 164:370-376.
79. Aune D, Chan DS, Greenwood DC, et al. Dietary fiber and breast cancer risk: a systematic review and meta-analysis of prospective studies. Ann Oncol 2012; 23:1394-1402.
80. Pereira MA, Ludwig DS. Dietary fiber and body-weight regulation. Observa-tions and mechanisms. Pediatr Clin North Am 2001; 48:969-980.
81. Diaz MN, Frei B, Vita JA, Keaney JF Jr. Antioxidants and atherosclerotic heart disease. N Engl J Med 1997; 337:408-416.
82. Katsiki N, Manes C. Is there a role for supplemented antioxidants in the prevention of atherosclerosis? Clin Nutr 2009; 28:3-9.
83. Brigelius-Flohe R, Kluth D, Banning A. Is there a future for antioxidants in atherogenesis? Mol Nutr Food Res 2005; 49:1083-1089.
84. Osganian SK, Stampfer MJ, Rimm E, et al. Vitamin Cand riskofcoronaryheart disease in women. J Am Coll Cardiol 2003; 42:246-252.
85. Morris CD, Carson S. Routine vitamin supplementation to prevent cardio-vasculardisease: a summary of the evidenceforthe U.S. Preventive Services Task Force. Ann Intern Med 2003; 139:56-70.
86. Sofi F, Abbate R, Gensini GF, Casini A. Accruing evidence on benefits of adherencetothe Mediterranean dieton health: an updated systematic review and meta-analysis. Am J Clin Nutr 2010; 92:1189-1196.
87. Taku K, Umegaki K, Sato Y, et al. Soy isoflavones lower serum total and LDL cholesterol in humans: a meta-analysis of 11 randomized controlled trials. Am J Clin Nutr 2007; 85:1148-1156.
88. Dewell A, Hollenbeck PL, Hollenbeck CB.Clinical review: acriticalevaluation of the role of soy protein and isoflavone supplementation in the control of plasma cholesterol concentrations. J Clin Endocrinol Metab 2006; 91:772-780.
89. Gardner EJ, Ruxton CH, Leeds AR. Blacktea: helpful or harmful? A reviewof the evidence. Eur J Clin Nutr 2007; 61:3-18.
90. Liu J, Zhang J, Shi Y, et al. Chinese red yeast rice (Monascus purpureus) for primary hyperlipidemia: a meta-analysis of randomized controlled trials. Chin Med 2006; 1:4.
91. Sofi F, Conti AA, Gori AM, et al. Coffeeconsumption and riskofcoronaryheart disease: a meta-analysis. Nutr Metab Cardiovasc Dis 2007; 17:209-223.
92. Lu Z, Kou W, Du B, et al. Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction. Am J Cardiol 2008; 101:1689-1693.
93. Wu JN, Ho SC, Zhou C, et al. Coffee consumption and risk of coronary heart diseases: a meta-analysis of 21 prospective cohort studies. Int J Cardiol 2009; 137:216-225. Ciencia, Proyectos de Investigación de Excelencia, Junta de Andalucía Ciencia, Proyectos de Investigación de Excelencia, Junta de Andalucía Ciencia, Proyectos de Investigación de Excelencia, Junta de Andalucía